New quantitative data suggests that 30% of the surgeries performed for non-small cell lung cancer patients in a community-wide clinical study were deemed unnecessary.
Big data analytics has predicted if a patient is suffering from aggressive triple-negative breast cancer, slower-moving cancers, or noncancerous lesions with 95% accuracy.
The risk of early relapse is increased when radiotherapy is omitted in patients with stage I/II Hodgkin lymphoma whose PET scan findings are negative, according to an interim trial analysis.
The increasing use of expensive medical imaging procedures in the United States is being driven, in part, by patient decisions made after obtaining information from lay media and nonexperts.
Three-dimensional biopsies find more prostate cancers, particularly in the anterior regions, than those guided by ultrasound, according to a new clinical study.
A new type of magnetic resonance imaging (MRI) scan, known as diffusion-weighted MRI, could improve care for myeloma and reduce reliance on bone marrow biopsies.
Respiratory motion management reduces radiation exposure to nontarget tissues in patients undergoing treatment of cancers in the chest and abdomen.
High-risk adults age 55 to 80 years should receive annual lung cancer screening with low-dose computed tomography.
Imaging with a molecular imaging tracer can help distinguish radiation-induced lesions from new tumor growth in patients who have been treated with radiation for brain metastases, according to new research.
Drastic reimbursement cuts for image-guided breast biopsies, and other medical imaging techniques in the 2014 Medicare Fee Schedule Final Rule, may further reduce women's access to mammography and other breast cancer services.
Compared with traditional mammography, 3D mammography—known as digital breast tomosynthesis—found 22% more breast cancers and led to fewer callbacks in a large screening study, as researchers reported at the annual meeting of the Radiological Society of North America.
An optical imaging technique that measures metabolic activity in cancer cells can accurately differentiate breast cancer subtypes, and can detect responses to treatment as early as 2 days after therapy administration.
Thyroid cancer discovered during imaging that is being performed for reasons other than evaluation of that gland is often similar to nonincidentally discovered thyroid cancer in terms of tumor size, pathology, and behavior.
Higher tumor uptake of a radiotracer used in positron emission tomography (PET) appears to be a predictor of worse survival in persons who have undergone treatment for stage III non-small cell lung cancer.
Substantial tumor regressions among some patients with advanced pancreatic cancer occurred in a recent clinical trial that paired the standard chemotherapy for pancreatic cancer, gemcitabine, with an agonist CD40 antibody.
Breast lesions categorized as probably benign on supplemental ultrasound screening could be re-evaluated via imaging in 12 months, according to a multisite imaging trial.
There has been increasing incidence of small and indolent thyroid cancer but mortality rate has been stable since 1979.
Assessing bone marrow involvement in persons with a new diagnosis of diffuse large B-cell lymphoma (DLBCL) is better accomplished with 18F-FDG positron emission tomography/computed tomography (PET/CT).
Combining tomosynthesis with digital mammography lowered recall rates by 30% among women being screened for breast cancer, with the greatest reductions seen in patients younger than age 50 years and in those with dense breasts.
Some women with ALH or LCIS can delay or avoid surgery and instead undergo periodic imaging and clinical examination, as long as radiology and pathology findings are benign and concordant.
The Society of Thoracic Surgeons (STS) has released new clinical-practice guidelines that feature evidence-based recommendations to help clinicians diagnose and stage esophageal cancer.
Persons with limited-stage small cell lung cancer (LS-SCLC) exhibited better disease control and survival when staged with positron emission tomography (PET) than did patients who did not undergo staging with PET.
Tiny biosensors used with new advanced imaging techniques are markedly improving drug targeting of solid tumors, according to new research.
For patients with advanced breast cancer, PET and MRI can improve quality of life and survival by providing physicians with information on chemotherapy effectiveness prior to surgery.
Depending on the recall strategy, integrated mammography strategy can reduce false-positive recall.
The imaging technique of DTI allows neurosurgeons to visualize important pathways in the brain. This allows them to better adapt brain tumor surgeries and preserve language, visual function, and motor function while removing cancerous tissue.
Two noninvasive technologies detected tumor response to therapy weeks earlier than tumor volume changes reflected.
Fluorescence form 5-aminolevulinic acid (5-ALA) has been used to guide resection of recurrent GBM. Before surgery, the patient ingests 5-ALA, then the tumor cells fluoresce intraoperatively in response to certain wavelengths of light.
The radiation dose to areas of the body near the breast during mammography is negligible, or very low, and does not result in an increased risk of cancer, according to a new study.
Adding three-dimensional breast imaging to standard digital mammography increases diagnostic accuracy and reduces false-positive recall rates.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|